ScholarWorks@SOONCHUNHYANG UNIVERSITY: BAEK, AE RIN

Detailed Information

BAEK, AE RIN (백애린)

College of Medicine (Department of Internal Medicine)

Research Area

Tel
E-mail
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Asthma:4||COVID19:4||idiopathic pulmonary fibrosis:2||COPD:2||Mortality:2||Korea:2||CEA:1||CYFRA 211:1||Classification:1||Coinfection:1||Critical care:1||DNA methylation:1||Diagnosis:1||Epidemiology:1||EpithelialMesenchymal Transition:1||FPR2:1||General ward:1||HRCT:1||HealthcareAssociated Pneumonia:1||Healthcareassociated pneumonia:1||Idiopathic Interstitial Pneumonias:1||Interstitial:1||Lung Diseases:1||Microbiology:1||Nacetylcysteine:1||NSCLC:1||Nectin4:1||Nrf2:1||Ovalbumin:1||Oxygen inhalation therapy:1||PM:1||Prognosis:1||Pulmonary Fibrosis:1||ROS:1||Respiration:1||SARSCoV2:1||Spermidine attenuates bleomycininduced lung fibrosis by inducing autophagy and inhibiting endoplasmic reticulum stress (ERS)induced cell death in mice:1||Steroids:1||Tight junctions:1||Transforming Growth Factor Betal:1||VentilatorAssociated Pneumonia:1||adherens junction protein:1||air pollutants:1||airway disease:1||antinuclear antibody:1||apoptosis:1||asthma:1||biologics:1||cell barrier:1||claudin4:1||claudin5:1||critical care:1||elderly:1||epithelial barrier:1||erdosteine:1||fibroblasts:1||gene expression:1||innate immune response:1||lung function:1||mortality.:1||nanoparticles:1||necroptosis:1||necrostatin:1||neutrophilc inflammation:1||particulate matter:1||prognostic factor:1||proteomics:1||receptorinteracting protein kinase3:1||remodeling:1||rheumatoid factor:1||therapeutic target:1||tumor marker:1||Airway epithelial:1||호흡기내과:1||Annexin A1:1||Apolipoprotein A1:1||Artificial:1||Bacterial infections:1||Blood:1||

STATISTICS: Total View :1,214,937; Today View :4,612

RSS_1.0 RSS_2.0 ATOM_1.0

(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE